Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention

American Journal of Cardiology

Volumn 95, Issue 10, 2005, Pages 1235-1237

  Takase, Hiroyuki ^b   Toriyama, Takayuki ^b   Sugiyama, Masaya ^b   Nakazawa, Ai ^b   Hayashi, Kunihiko ^b   Goto, Takatoshi ^b   Sugiura, Tomonori ^b   Ikeda, Koshiro ^b   Sato, Koichi ^b   Ueda, Ryuzo ^b   Dohi, Yasuaki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; NIFEDIPINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HUMAN; INFLAMMATION; LONG TERM CARE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; STABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 20944438850     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.01.054     Document Type: Article

References (15)

1. N. Rifai, R.P. Tracy, P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 1999 2136 2141
2. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1982 131 138
3. P.M. Ridker High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention Am J Cardiol 92 suppl 2003 17K 22K
4. S. McDonald, G. Maguire, N. Duarte, X.L. Wang, W. Hoy C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community Clin Sci 106 2004 121 128
5. K. Yasojima, C. Schwab, E.G. McGeer, P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 2001 1039 1051
6. V. Pasceri, J.T. Willerson, E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
7. V. Pasceri, J.S. Cheng, J.T. Willerson, E.T. Yeh, J. Chang Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534
8. N. Sattar Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin Sci 106 2004 443 445
9. S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, S. Favilla, A. Pompella, A. Salvetti Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension Hypertension 37 2001 943 948
10. K. Fukuo, J. Yang, O. Yasuda, M. Mogi, T. Suhara, N. Sato, T. Suzuki, S. Morimoto, T. Ogihara Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways Circulation 106 2002 356 361
11. S. Yamagishi, Y. Inagaki, S. Kikuchi Nifedipine inhibits tumor necrosis factor-alpha-induced monocyte chemoattractant protein-1 overexpression by blocking NADPH oxidase-mediated reactive oxygen species generation Drugs Exp Clin Res 29 2003 147 152
12. A. Matsumori, Y. Nunokawa, S. Sasayama Nifedipine inhibits activation of transcription factor NF-κB Life Sci 67 2000 2655 2661
13. D.G. Harrison Cellular and molecular mechanisms of endothelial cell dysfunction J Clin Invest 100 1997 2153 2157
14. The ENCORE Investigators Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease The ENCORE I study (evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function) Circulation 107 2003 422 428
15. The ACTION Investigators Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial Lancet 364 2004 849 857